Global Cord Blood Banking Market Size And Forecast
According to Verified Market Research, The Global Cord Blood Banking market was valued at USD 1.39 Billion in 2018 and is projected to reach USD 3.87 Billion by 2026, growing at a CAGR of 13.7% from 2019 to 2026.
The latest survey on Global Cord Blood Banking Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunity available and trend in Cord Blood Banking Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Cord Blood Banking Market By Raw Material, By End User, By Region - North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities
What Is Cord Blood Banking?
Cord Blood is the blood from the baby that is left in the umbilical cord and placenta after birth. It contains special cells viz. hematopoietic stem cells, hematopoietic progenitor cells which are also found in bone marrow and peripheral blood; that can be used to treat nearly 80 types of diseases including blood cancers like leukemia and lymphoma. Cord blood is usually considered the safest source of stem cells. Removing stem cells from the umbilical cord is painless for the mother and completely safe for her child. Collected cord blood can be stored successfully at private as well as public blood banks for several decades.
Global Cord Blood Banking Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Cord blood is used to treat immune diseases, metabolic disorders, cancers viz. leukemia and lymphoma. The increasing awareness about the important and safe removal process of cord blood can drive the cord blood banking market. In-vivo CRO based treatments and increase in CROs are creating opportunities for the market growth. The exorbitant initial cost and the consecutive costs incurred for private banks services might hamper the market growth. The stored blood only be last for 15 years. Stem cells cannot be used to cure genetic diseases as it is also there in the stem cells. Such factors can also be challenges to the market.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Cord Blood Banking Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.
Global Cord Blood Banking Market Competitive Landscape
The "Global Cord Blood Banking Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as CBR Systems, Inc., China Cord Blood Corporation, Cord Blood America, Inc., Cordlife Group Ltd., Cryo-Cell International, Inc., Cryo-Save AG, LifeCell, StemCyte Inc., ViaCord Inc., and Vita 34 AG. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1 INTRODUCTION OF GLOBAL CORD BLOOD BANKING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CORD BLOOD BANKING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
5 GLOBAL CORD BLOOD BANKING MARKET, BY STORAGE SERVICES
5.1 Overview
5.2 Private Cord Blood Bank
5.3 Public Cord Blood Bank
6 GLOBAL CORD BLOOD BANKING MARKET, BY APPLICATION
6.1 Overview
6.2 Cancers
6.3 Blood Disorders
6.4 Metabolic Disorders
6.5 Immune Disorders
6.6 Osteopetrosis
6.7 Others
7 GLOBAL CORD BLOOD BANKING MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 Middle East
8 GLOBAL CORD BLOOD BANKING MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 CBR Systems, Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 China Cord Blood Corporation
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Cord Blood America, Inc.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Cordlife Group Ltd.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Cryo-Cell International, Inc.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Cryo-Save AG
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 LifeCell
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 StemCyte Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 ViaCord Inc.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Vita 34 AG
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Research
Market Overview
The Asia Pacific FinTech Investment Market is poised for significant expansion from 2024 to 2034. With an initial valuation of USD XX.XX billion in 2024, the market is forecasted to reach USD XX.XX billion by 2034, reflecting a robust compound annual growth rate (CAGR) o...
Market Overview
The Europe FinTech Investment Market is poised for significant expansion from 2024 to 2034, driven by rapid technological advancements, evolving consumer preferences, and the increasing integration of digital finance solutions. The market is expected to reach a valuation...
Market Overview
The North America FinTech Investment Market is set to experience substantial growth from 2024 to 2034, driven by an accelerated adoption of innovative financial technologies across various sectors. The market, which encompasses investments in a wide range of FinTech solu...
Market Overview
The Global FinTech Investment Market is set for substantial growth from 2024 to 2034, propelled by rapid technological advancements and the increasing adoption of digital financial solutions. FinTech, which merges financial services with technology, is revolutionizing ho...
The Blood Bank Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Market Overview
The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...
Market Overview
The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...
Market Overview
The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...
Market Overview
The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...